Rübsamen-Waigmann, H <br/><br/>
Resistance mutations selected in vivo under therapy with anti-HIV drug HBY 097 differ from resistance pattern selected in vitro.  [electronic resource] 

 -  Antiviral research  May 1999 
 - 15-24 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0166-3542 
<br/><br/><label>Standard No.: </label>10.1016/s0166-3542(99)00010-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiviral Agents<br/>Dose-Response Relationship, Drug<br/>Drug Resistance, Microbial--genetics<br/>Genotype<br/>HIV Infections--drug therapy<br/>HIV-1--drug effects<br/>Humans<br/>Mutation<br/>Phenotype<br/>Quinoxalines--pharmacology<br/>Reverse Transcriptase Inhibitors--pharmacology<br/>Viral Load